The RB1 depletion-associated signature32 (“RB-loss signature”) was specifically enriched in Group NE tumors, consistent with universal RB1 disruption in both PSCCE and SCLC (Fig. 3f). This evidence concerns the gene RB1 and small cell lung carcinoma.